Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial
Titel:
Pembrolizumab with or without bevacizumab in platinum-resistant recurrent or metastatic nasopharyngeal carcinoma: a randomised, open-label, phase 2 trial
Auteur:
Chong, Wan-Qin Low, Jia-Li Tay, Joshua K Le, Thi Bich Uyen Goh, Grace Shi-Qing Sooi, Kenneth Teo, Hui-Lin Cheo, Seng-Wee Wong, Regina Tong-Xin Samol, Jens Lim, Ming-Yann Li, Hao Shirgaonkar, Niranjan Chia, Shumei Wang, Lingzhi Gopinathan, Anil Eu, Donovan Kum-Chuen Tsang, Raymond King-Yin Loh, Kwok-Seng Toh, Han-Chong Syn, Nicholas Kong, Li-Ren Dasgupta, Ramanuj Tai, Bee-Choo Lim, Yaw-Chyn Goh, Boon-Cher